Volume 132, Issue 3, Pages (March 2007)

Slides:



Advertisements
Similar presentations
Volume 115, Issue 4, Pages (October 1998)
Advertisements

Christian F. Krieglstein, Christoph Anthoni, Wolfgang H
Volume 131, Issue 4, Pages (October 2006)
Volume 138, Issue 2, Pages e3 (February 2010)
Volume 136, Issue 2, Pages e5 (February 2009)
Volume 135, Issue 1, Pages (July 2008)
Volume 140, Issue 2, Pages e2 (February 2011)
Volume 133, Issue 4, Pages (October 2007)
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 135, Issue 4, Pages (October 2008)
Volume 136, Issue 1, Pages (January 2009)
Volume 135, Issue 2, Pages e3 (August 2008)
Volume 132, Issue 4, Pages (April 2007)
Daniel K. Podolsky, Guido Gerken, Annette Eyking, Elke Cario 
B Cells That Produce Immunoglobulin E Mediate Colitis in BALB/c Mice
Volume 129, Issue 1, Pages (July 2005)
Volume 138, Issue 4, Pages (April 2010)
Volume 131, Issue 4, Pages (October 2006)
Volume 143, Issue 5, Pages e4 (November 2012)
Volume 141, Issue 2, Pages e4 (August 2011)
Volume 141, Issue 5, Pages (November 2011)
Volume 144, Issue 5, Pages e6 (May 2013)
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 134, Issue 1, Pages e1 (January 2008)
Volume 137, Issue 3, Pages (September 2009)
Volume 24, Issue 5, Pages (November 2013)
Volume 132, Issue 3, Pages (March 2007)
This month in Gastroenterology
Volume 136, Issue 3, Pages (March 2009)
Volume 136, Issue 2, Pages (February 2009)
Volume 130, Issue 2, Pages (February 2006)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 139, Issue 6, Pages (December 2010)
Volume 139, Issue 6, Pages (December 2010)
Volume 138, Issue 2, Pages e3 (February 2010)
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice  Tohru Funakoshi, Kenichiro Yamashita, Nobuki.
Volume 140, Issue 2, Pages e4 (February 2011)
Volume 132, Issue 5, Pages (May 2007)
Volume 143, Issue 1, Pages (July 2012)
Volume 142, Issue 4, Pages e2 (April 2012)
Volume 36, Issue 2, Pages (February 2012)
Volume 141, Issue 3, Pages e1 (September 2011)
Volume 138, Issue 4, Pages (April 2010)
Volume 125, Issue 6, Pages (December 2003)
This Month in Gastroenterology
Suppression of Apoptosis, Crypt Hyperplasia, and Altered Differentiation in the Colonic Epithelia of Bak-Null Mice  Carrie A. Duckworth, D. Mark Pritchard 
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Volume 40, Issue 2, Pages (February 2014)
A Mouse Model of Clostridium difficile–Associated Disease
Volume 116, Issue 4, Pages (April 1999)
The PepT1–NOD2 Signaling Pathway Aggravates Induced Colitis in Mice
Volume 136, Issue 2, Pages e2 (February 2009)
Volume 146, Issue 7, Pages e4 (June 2014)
Volume 131, Issue 6, Pages (December 2006)
A2B Adenosine Receptor Gene Deletion Attenuates Murine Colitis
Volume 135, Issue 2, Pages e2 (August 2008)
Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis  Basilia Zingarelli,
Volume 128, Issue 4, Pages (April 2005)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 138, Issue 3, Pages e5 (March 2010)
Leptin: A pivotal mediator of intestinal inflammation in mice
Volume 141, Issue 3, Pages (September 2011)
Helminth Infection Enhances Disease in a Murine TH2 Model of Colitis
Volume 127, Issue 5, Pages (November 2004)
The impact of primary and persistent cytomegalovirus infection on the progression of acute colitis in a murine model  Jerry L. Brunson, Felix Becker,
Volume 139, Issue 2, Pages (August 2010)
Colonic bacterial superantigens evoke an inflammatory response and exaggerate disease in mice recovering from colitis  Jun Lu, Arthur Wang, Sara Ansari,
Volume 131, Issue 2, Pages (August 2006)
Volume 136, Issue 7, Pages (June 2009)
Volume 120, Issue 4, Pages (March 2001)
Presentation transcript:

Volume 132, Issue 3, Pages 955-965 (March 2007) CD40–CD40 Ligand Mediates the Recruitment of Leukocytes and Platelets in the Inflamed Murine Colon  Thorsten Vowinkel, Christoph Anthoni, Katherine C. Wood, Karen Y. Stokes, Janice Russell, Laura Gray, Sulaiman Bharwani, Norbert Senninger, J. Steven Alexander, Christian F. Krieglstein, Matthew B. Grisham, D. Neil Granger  Gastroenterology  Volume 132, Issue 3, Pages 955-965 (March 2007) DOI: 10.1053/j.gastro.2006.12.027 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Effects of DSS (vs H2O) treatment (day 0–day 6) on the expression of CD40 in the vasculature of the proximal and distal colon in WT mice at day 6. Zero denotes no detectable expression. Data are presented as the mean ± SE. *Denotes statistical significance (P < .05) compared with corresponding control (H2O). Gastroenterology 2007 132, 955-965DOI: (10.1053/j.gastro.2006.12.027) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 Changes in the disease activity index (A) and body weight (%) (B) over the course of DSS (or H2O) treatment in WT, CD40-deficient (CD40−/−), and CD40L-deficient (CD40L−/−) mice. Data are presented as the mean ± SE. *P < .05 vs H2O, #P < .05 vs DSS. Gastroenterology 2007 132, 955-965DOI: (10.1053/j.gastro.2006.12.027) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 Length of the resected colon (cm) at day 6 of DSS (or H2O) treatment in WT, CD40-deficient (CD40−/−), and CD40L-deficient (CD40L−/−) mice. Data are presented as the mean ± SE. *P < .05 vs H2O, #P < .05 vs DSS. Gastroenterology 2007 132, 955-965DOI: (10.1053/j.gastro.2006.12.027) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 Blinded histologic assessment of colonic mucosa at day 6 of DSS (or H2O) treatment in WT, CD40-deficient (CD40−/−), and CD40L-deficient (CD40L−/−) mice. Zero denotes no detectable response in H2O-treated WT mice. The total histologic score was derived from the severity and extent of inflammation and crypt damage. For each mouse, 3 sections were analyzed (mean ± SE). * and # denote statistical significance (P < .05) compared with control and WT DSS-treated animals, respectively. Gastroenterology 2007 132, 955-965DOI: (10.1053/j.gastro.2006.12.027) Copyright © 2007 AGA Institute Terms and Conditions

Figure 5 Histology (H&E staining; magnification ×100) of colonic samples taken at day 6 from WT animals receiving H2O (control) or from WT, CD40−/−, and CD40L−/− mice receiving DSS in drinking water. Compared with the colon of control animals (A), the colon of WT DSS-treated mice (B) showed destruction of the bowel wall architecture with loss of the epithelial lining (arrowheads), vanished crypts, submucosal edema (asterisk), and dense cellular inflammation in all layers (arrows). Histologic specimens of CD40−/− (C) and CD40L−/− (D) mice exhibited an attenuated morphologic damage with only mild cellular infiltration (arrow). Gastroenterology 2007 132, 955-965DOI: (10.1053/j.gastro.2006.12.027) Copyright © 2007 AGA Institute Terms and Conditions

Figure 6 Colonic myeloperoxidase (MPO) activity at day 6 in H2O-treated WT mice and WT, CD40−/−, and CD40L−/− mice receiving DSS in drinking water from day 0–day 6. *P < .05 vs water, #P < .05 vs DSS. Gastroenterology 2007 132, 955-965DOI: (10.1053/j.gastro.2006.12.027) Copyright © 2007 AGA Institute Terms and Conditions

Figure 7 Rolling platelets (A) and leukocytes (B) and firmly adherent platelets (C) and leukocytes (D) in postcapillary venules on day 6 of treatment with H2O (WT control) or DSS in WT, CD40−/−, and CD40L−/− mice. The number of platelets bound to leukocytes (platelet–leukocyte interactions) and those bound directly to endothelium (platelet–endothelial interactions) are shown in A and C. The number of platelet-bearing and platelet-free rolling and adherent leukocytes are presented in B and D. *P < .05 relative to H2O, #P < .05 relative to WT mice treated with DSS &P < .05 relative to CD40−/−. Gastroenterology 2007 132, 955-965DOI: (10.1053/j.gastro.2006.12.027) Copyright © 2007 AGA Institute Terms and Conditions